Pursuing OEM supply following a 6-month technology verification and expanding into the global microsurgery market.
MediThinQ has signed a supply agreement for a 3D surgical visualization solution with the U.S. medical company Baxter. The solution is a medical device applied in the field of microsurgery, and the collaboration is being pursued to expand into the global market.
MediThinQ announced on the 9th that it has signed a global exclusive supply and distribution agreement with Baxter for its 3D surgical visualization solution 'SHIYA'.
This contract was signed following a technical verification process that lasted approximately six months. SHIYA will be supplied under the Baxter brand and is expected to be widely applied to microsurgery sites worldwide.
SHIYA is a surgical visualization platform that provides a 3D image of the surgical site.
Key features include △capable of 3D video at up to 20x magnification △linkage with the wearable display 'SCOPEYE' △real-time video sharing △support for 4K recording.
This technology is utilized as digital surgical equipment that replaces or complements existing optical microscope-based surgical environments. The company explained that this enables improvements to the surgical environment and facilitates educational applications.
MediThinQ announced that research related to SHIYA was published in the medical journals JPRAS Open (2025) and PRS (2026). This study addresses the clinical applicability and scalability of digital exoskeleton technology.
The company plans to expand its presence in major markets, including the U.S. and Europe, by leveraging Baxter's global distribution network. Baxter is a company with a medical equipment supply network in the field of microsurgery.
They also stated that they are considering future expansions that combine surgical data-based functions with AI and augmented reality (AR) technologies.
Medisync added that through this contract, it plans to expand its business related to the digitalization of operating rooms and also proceed with preparations for an initial public offering (IPO).